
General Orthopaedics
RA: Addition of etanercept to methotrexate increases remission rates
This report has been verified
by one or more authors of the
original publication.
Lancet. 2008 Aug 2;372(9636):375-82. Epub 2008 Jul 16
542 patients with adult-onset rheumatoid arthritis were randomized to either receive a combination treatment of both etanercept and methotrexate, or just treatment with methotrexate. The results at 1 year indicated that the combination of etanercept and methotrexate resulted in high remission rates and was effective in arresting radiographic progression of joint damage.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.